radioisotope therapy

RADIATION6 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Radiation Therapy Oncology Group, Children's Hospital Medical Center, Cincinnati, AIDS Malignancy Consortium, Children's Cancer and Leukaemia Group

Conditions

AIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell LymphomaEsophageal CancerGastric CancerNeuroblastomaSarcoma

Phase 2

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

CompletedNCT00002634

Memorial Sloan Kettering Cancer CenterNeuroblastoma

Start: 1995-02-28End: 2004-09-30Target: 45Updated: 2013-07-03

Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma

CompletedNCT00002791

Radiation Therapy Oncology GroupSarcoma

Start: 1997-02-28End: 2013-11-30Updated: 2014-01-24

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

WithdrawnNCT00310128

AIDS Malignancy ConsortiumAdult Non-Hodgkin's Lymphoma, AIDS-related Lymphoma, Anaplastic Large Cell Lymphoma

Start: 2006-02-28Updated: 2016-02-03

High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

WithdrawnNCT00389766

Children's Cancer and Leukaemia GroupNeuroblastoma

Start: 2008-07-31Updated: 2013-07-10

Phase 3

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

CompletedNCT00002802

Children's Hospital Medical Center, CincinnatiNeuroblastoma

Start: 1990-07-31End: 2003-09-30Target: 500Updated: 2013-12-19

Unknown Phase

Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer

CompletedNCT00629863

North Wales Organisation for Randomised Trials in HealthEsophageal Cancer, Gastric Cancer

Start: 2004-09-30End: 2010-01-31Target: 700Updated: 2013-08-07

Related Papers

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial

Nature Communications2025-02-1415 citations

Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy

JAMA Oncology2023-03-3038 citations

Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation

Sarcoma2018-01-0110 citations